LRCX:NASDAQLam Research Corporation Analysis
Data as of 2026-05-30 - not real-time
$318.18
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Lam Research is trading at $318.18, comfortably above its 20‑day ($293.11), 50‑day ($263.71) and 200‑day ($192.87) moving averages, and the MACD shows a bullish crossover (line $15.10 vs signal $13.14). The RSI sits at 66, indicating momentum but edging toward overbought territory, while volatility is elevated at 52% over the past 30 days and beta is high at 2.74, suggesting a very reactive price profile. Valuation metrics are stretched: the forward PE of 40 compares unfavorably to the industry average of 41.86, the trailing PE of 60 is well above peers, and the DCF‑derived fair value of $121.41 implies the stock is severely overvalued with a downside bias of –1.4% versus current levels. Fundamentally, the company delivers robust growth – revenue is up 23.8% year‑over‑year, gross margin is ~50%, operating margin ~35%, and ROE is an eye‑popping 66%, supported by strong free cash flow of $4.35 B and a modest payout ratio of 19% (dividend yield 0.33%). Analyst sentiment remains positive, with a consensus “Buy” and a median price target of $315, but that target is already below the market price, limiting upside. The AI‑driven semiconductor boom and expanding demand for advanced chip manufacturing provide a compelling long‑run narrative, even as short‑term price pressures from high valuation and market sentiment pose a risk.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price trading above fair value and near resistance
- High beta and volatility increasing downside risk
- Limited upside given consensus target below current price
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong cash generation and expanding AI chip demand
- Valuation compression risk as market re‑prices growth
- Stable dividend with low payout supporting cash flow durability
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Secular AI‑driven semiconductor equipment demand
- Exceptional profitability metrics (high margins, ROE)
- Robust balance sheet with ample cash and manageable debt
Key Metrics & Analysis
Financial Health
Revenue Growth23.80%
Profit Margin30.94%
P/E Ratio60.3
ROE66.76%
ROA22.78%
Debt/Equity35.28
P/B Ratio37.6
Op. Cash Flow$7.0B
Free Cash Flow$4.4B
Industry P/E41.9
Technical Analysis
TrendBullish
RSI66.1
Support$250.12
Resistance$333.33
MA 20$293.11
MA 50$263.71
MA 200$192.87
MACDBullish
VolumeStable
Fear & Greed Index94.07
Valuation
Fair Value$121.41
Target Price$313.69
Upside/Downside-1.41%
GradeOvervalued
TypeGrowth
Dividend Yield0.33%
Risk Assessment
Beta2.74
Volatility52.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.